Key result
Implantable cardioverter-defibrillator therapy continues to face persistent access barriers within and across countries despite its role in preventing sudden cardiac death.
Highlights persistent barriers to accessing implantable cardioverter-defibrillator therapy globally.
Persistent global ICD access barriers warrant targeted policy interventions; leaves open scalable solutions for equitable delivery.
Implantable cardioverter-defibrillators (ICDs) are a cornerstone in the prevention of sudden cardiac death (SCD), one of the leading causes of mortality worldwide. These devices offer an evidence-...
No takes yet. Share an insight, caveat, or question.
Imberti et al. (2025) studied this question. Implantable cardioverter-defibrillator therapy continues to face persistent access barriers within and across countries despite its role in preventing sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: